Elan Inks $204M Deal In Zonegran Off-Label Probe
By Jocelyn Allison ( July 16, 2010, 11:51 AM EDT) -- Irish drugmaker Elan Corp. PLC has said it will pay $203.5 million and plead guilty to a misdemeanor criminal charge to settle a federal investigation into its sales and marketing practices for the epilepsy drug Zonegran....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.